TOMI's SteraMist Enclosure Orders Hit $2.3M YTD, Up 44% vs Prior Four Years
TOMZ sits 15% above its 52-week low of $1.39 on light trading volume (0.1× avg).
Summary
TOMI disclosed $2.3M in year-to-date purchase orders for its SteraMist iHP enclosure product line, a 44% increase over the $1.6M generated in the previous four years combined. The company attributes the acceleration to its SteraMist Integration System (SIS) platform, which reduces customization and speeds delivery. Two recent retrofit orders are expected to contribute revenue in the second half of 2026, with services recognized next quarter. The company also reported a $3.2M active pipeline for Custom Engineered Systems. This follows the Q2 revenue growth of 118% and the $12M full-year guidance reaffirmed in July, indicating continued commercial traction despite the going concern warning and Nasdaq delisting risk.
At the time of this announcement, TOMZ was trading at $1.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13M. The 52-week trading range was $1.39 to $3.42. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.